Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JZB30 vs Gonal-f for controlled ovarian stimulation in ART
CTR20191979Phase 3Completed
- Sponsor
- Chengdu Bofa Biotechnology
- Start
- Oct 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human follicle-stimulating hormone (JZB30) in infertility, sponsored by Chengdu Bofa Biotechnology. Started Oct 2019; status: completed.
02
Drugs
recombinant human follicle-stimulating hormone (JZB30)
03
Conditions
infertility
Beyond the preview
Go deeper on CTR20191979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191979.